Vanda Pharmaceuticals (NASDAQ:VNDA) traded at a new 52-week high today of $8.60. Approximately 2 million shares have changed hands today, as compared to an average 30-day volume of 462,000 shares.
In the past 52 weeks, shares of Vanda Pharmaceuticals have traded between a low of $2.92 and a high of $8.60 and are now at $8.30, which is 184% above that low price. The 200-day and 50-day moving averages have moved 1.51% higher and 5.95% higher over the past week, respectively.
Vanda Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of a portfolio of clinical-stage, small molecule product candidates for central nervous system disorders.
Vanda Pharmaceuticals (NASDAQ:VNDA) has potential upside of 5.4% based on a current price of $8.30 and analysts' consensus price target of $8.75. The stock should discover initial support at its 50-day moving average (MA) of $4.72 and subsequent support at its 200-day MA of $4.07.